| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUCCCUCAGCGCCAUUUUGUGGCAGCGAGACCCACAAAUAAAGGGGAGC… | 2105 nt | 0.4418 | |
| CGCUUCCCUUACUGAGCUUGCUGAGCUCCGGGGCCCGCGGAGCUCGCGC… | 1507 nt | 0.4287 | |
| CUCCCUCAGCGCCAUUUUGUGGCAGCGAGACCCACAAAUAAAGGGGAGC… | 1488 nt | 0.4328 | |
| CGCUUCCCUUACUGAGCUUGCUGAGCUCCGGGGCCCGCGGAGCUCGCGC… | 2124 nt | 0.4388 | |
| CUCCCUCAGCGCCAUUUUGUGGCAGCGAGACCCACAAAUAAAGGGGAGC… | 1708 nt | 0.4333 | |
| CGCUUCCCUUACUGAGCUUGCUGAGCUCCGGGGCCCGCGGAGCUCGCGC… | 1727 nt | 0.4296 |
The Wilms tumor suppressor gene WT1 appears to play a role in both transcriptional and posttranscriptional regulation of certain cellular genes. This gene encodes a WT1-associating protein, which is a ubiquitously expressed nuclear protein. Like WT1 protein, this protein is localized throughout the nucleoplasm as well as in speckles and partially colocalizes with splicing factors. Alternative splicing of this gene results in several transcript variants encoding three different isoforms. [provided by RefSeq, Jul 2012]
A study in mice demonstrated that the WTAP knockdown induces G2 accumulation in human umbilical vein endothelial cells and reduces cyclin A2, while also facilitating desmoplakin mRNA m6A methylation to promote endothelial cell angiogenesis and inhibiting vascular smooth muscle cell proliferation but facilitating apoptosis [Chen et al. DOI:10.1155/2021/8813909].